The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond

por Chang, Lin-Chau
Publicado 2019

Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications

por Chang, Lin-Chau, Mahmood, Riaz, Qureshi, Samina, Breder, Christopher D.
Publicado 2017

The impact of the rare disease and Orphan Drug Act in Taiwan

por Hsiang, Ning-Chun, Huang, Weng-Foung, Gau, Churn-Shiouh, Tsai, Teng-Wen, Chang, Lin-Chau
Publicado 2021

Regulatory considerations for generic products of non-biological complex drugs

por Liu, Yu-Hsuan, Chen, Yi-Shuo, Tseng, Ting, Jiang, Min-Lin, Gau, Churn-Shiouh, Chang, Lin-Chau
Publicado 2023

Differences in Fatty Acid Oxidation between Nab-Paclitaxel- and Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics

por Huang, Jhih-Wei, Kuo, Ching-Hua, Kuo, Han-Chun, Shih, Jin-Yuan, Tsai, Teng-Wen, Chang, Lin-Chau
Publicado 2021

Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel

por Huang, Jhih-Wei, Kuo, Ching-Hua, Kuo, Han-Chun, Shih, Jin-Yuan, Tsai, Teng-Wen, Chang, Lin-Chau
Publicado 2021

Prognostic factors in epithelial ovarian cancer: A population-based study

por Chang, Lin-Chau, Huang, Chih-Fen, Lai, Mei-Shu, Shen, Li-Jiuan, Wu, Fe-Lin Lin, Cheng, Wen-Fang
Publicado 2018